Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
Papke RL
,
Porter Papke JK
.
???displayArticle.abstract???
1. Pharmacological studies of alpha7 nicotinic acetylcholine receptors are confounded by the fact that rapid desensitization to high agonist concentration causes alpha7 peak responses to occur well in advance of complete solution exchange. For this reason, peak currents are an invalid measure of response to applied agonist concentrations. We show that results comparable to those that have been corrected for instantaneous concentration are obtained if net charge is used as the measure of receptor response. 2. Dose response curves obtained with these methods indicate that alpha7 receptors are approximately 10 fold more sensitive to agonist than previously reported. The agonists, ACh, choline, cytisine, GTS-21, 4OH-GTS-21 and 4-MeO-CA have the same rank order potency for both human and rat receptors: 4-MeO-CA > 4OH-GTS-21 > GTS-21 > cytisine > ACh > choline. However, differences in efficacy exist between rat and human receptors. GTS-21 is more efficacious for rat than human alpha7 receptors and cytosine more efficacious for human than rat alpha7 receptors. 3. Choline is the least potent agonist for both human and rat alpha7, with a potency approximately 10 fold lower than that of ACh. While the EC50 for the activation of alpha7 receptors by choline (400-500 microM) is outside the normal physiological range (10-100 microM), choline can nonetheless produce detectable levels of channel activation in the physiological concentration range. Since these concentrations are relatively non-desensitizing, the contribution of choline-activated alpha7 receptor current may play a significant role in the regulation of calcium homeostasis in alpha7-expressing neurons.
Adams,
Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons.
1992, Pubmed
Adams,
Calcium permeability and modulation of nicotinic acetylcholine receptor-channels in rat parasympathetic neurons.
1992,
Pubmed
Alkondon,
Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.
1997,
Pubmed
Alkondon,
Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
1995,
Pubmed
Amador,
Mechanism for modulation of nicotinic acetylcholine receptors that can influence synaptic transmission.
1995,
Pubmed
Amar,
Agonist pharmacology of the neuronal alpha 7 nicotinic receptor expressed in Xenopus oocytes.
1993,
Pubmed
,
Xenbase
Bertrand,
Pharmacological properties of the homomeric alpha 7 receptor.
1992,
Pubmed
,
Xenbase
Bonfante-Cabarcas,
Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. IV. Regulation by external Ca++ of alpha-bungarotoxin-sensitive receptor function and of rectification induced by internal Mg++.
1996,
Pubmed
Briggs,
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.
1997,
Pubmed
Briggs,
Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists.
1998,
Pubmed
,
Xenbase
Buchman,
The effect of lecithin supplementation on plasma choline concentrations during a marathon.
2000,
Pubmed
Chavez-Noriega,
Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Couturier,
A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.
1990,
Pubmed
,
Xenbase
Dajas-Bailador,
The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism.
2000,
Pubmed
Fossati,
Determination of plasma choline by high-performance liquid chromatography with a postcolumn enzyme reactor and electrochemical detection.
1994,
Pubmed
Gopalakrishnan,
Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor.
1995,
Pubmed
,
Xenbase
Houlihan,
Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors.
2001,
Pubmed
,
Xenbase
Jope,
Seizures increase acetylcholine and choline concentrations in rat brain regions.
1991,
Pubmed
Kaneko,
Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors.
1997,
Pubmed
Kempsill,
Agonist activation and alpha-bungarotoxin inhibition of wild type and mutant alpha7 nicotinic acetylcholine receptors.
1999,
Pubmed
,
Xenbase
Kihara,
alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.
2001,
Pubmed
Klein,
Uptake and metabolism of choline by rat brain after acute choline administration.
1992,
Pubmed
Krause,
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.
1998,
Pubmed
,
Xenbase
Li,
Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells.
1999,
Pubmed
,
Xenbase
Lindstrom,
Nicotinic acetylcholine receptors in health and disease.
1997,
Pubmed
Macor,
The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.
2001,
Pubmed
,
Xenbase
Meyer,
Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties.
1998,
Pubmed
,
Xenbase
Meyer,
Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
1998,
Pubmed
,
Xenbase
Miao,
Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain.
1998,
Pubmed
Mike,
Choline and acetylcholine have similar kinetic properties of activation and desensitization on the alpha7 nicotinic receptors in rat hippocampal neurons.
2000,
Pubmed
Mott,
Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.
2001,
Pubmed
,
Xenbase
Papke,
An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype.
1996,
Pubmed
,
Xenbase
Papke,
Activation and inhibition of rat neuronal nicotinic receptors by ABT-418.
1997,
Pubmed
,
Xenbase
Papke,
The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Papke,
alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
2000,
Pubmed
Papke,
The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype.
2000,
Pubmed
,
Xenbase
Scremin,
Time-dependent changes in cerebral choline and acetylcholine induced by transient global ischemia in rats.
1991,
Pubmed
Shimohama,
Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.
2001,
Pubmed
Strahlendorf,
Choline blocks AMPA-induced dark cell degeneration of Purkinje neurons: potential role of the alpha7 nicotinic receptor.
2001,
Pubmed
Séguéla,
Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.
1993,
Pubmed
,
Xenbase
Uteshev,
Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors.
2002,
Pubmed
Vernino,
Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors.
1992,
Pubmed
,
Xenbase
de Fiebre,
Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
1995,
Pubmed
,
Xenbase
